Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 9/20 | 0.54 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 8/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14725635 | 0.94 | CYP11B1 (0.47) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL16472921 | 0.93 | CYP11B1 (0.49) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL16472865 | 0.91 | CYP11B1 (0.45) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL16472657 | 0.90 | CYP11B1 (0.44) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL14725756 | 0.90 | CYP11B1 (0.50) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL16472797 | 0.87 | CYP11B1 (0.43) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL16472708 | 0.86 | CYP11B1 (0.40) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL14725627 | 0.85 | TNKS (0.42) | RAB9AALOX5LIMK1 | |
| SCHEMBL14725748 | 0.84 | CYP11B1 (0.44) | CYP11B1HIPK2NPC1RAB9ACYP11B2 | |
| SCHEMBL16472775 | 0.84 | CYP11B1 (0.40) | CYP11B1HIPK2NPC1RAB9ACYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255084-B2 | Heterocyclic compound and organic light-emitting device containing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-09 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | TRPC1, TRPC4, TRPC6 | CYP11B1 887/4885HIPK2 2456/4885NPC1 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.